The metagenomics market size is calculated at USD 2.68 billion in 2025 and is expected to reach around USD 8.39 billion by ...

The oncology-based molecular diagnostics market is being propelled by the increasing prevalence of cancer worldwide and the ...

Wisconsin Physicians Service Insurance Corporation aligned its coverage determination with fellow contractor Palmetto GBA.

Shares of Tempus AI Inc (NASDAQ: TEM) are trading higher Wednesday, potentially building on momentum from last week given the ...

"This partnership reflects a shared vision—making high-quality, science-driven genetic testing more widely available," said Dr. Nguyen Hoai Nghia, Co-founder and CEO of Gene Solutions. "We believe ...

PacBio PACB announced last week its entry into the high-throughput carrier screening market with an expanded PureTarget portfolio powered by its HiFi sequencing technology. The new offering replaces ...

ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the ...

BACKGROUND: Alternative splicing plays crucial roles in normal heart development and cardiac disease by influencing protein-coding sequences, functional domains, and molecular networks. However, a ...

The NTRK Fusion Gene Positive Advanced Solid Tumors Market holds enormous potential as tumor-agnostic therapies reshape ...

BC, AOCNP, explains how ctDNA can inform prognosis, monitor disease progression, and guide treatment decisions in oncology.

Identifying the genetic factors that contribute to the development and progression of asthma is a significant area of research. Studies that leverage ...